Explore our blog
Biopharma in Flux: How to Lead Through 2025's Regulatory Whirlwind
Hannah Dersiewicz | EVP, Managing Director, Investor Relations & External Communications Greg Gregory, PhD | EVP,...
From KOL to DOL: Why the Influence Game Has Changed
The influence landscape in healthcare has fundamentally changed. While key opinion leaders (KOLs) still matter, digital...
Innovation, Personalization, and the Future of Oncology: How AI Is Transforming Cancer Care
Angie Norrell, PharmD, BCOP, CSP | Sr. Director, Access Experience Team, Market Access